J. Brooks Jackson - Concepedia

Author

J. Brooks Jackson

Also Known As

B JACKSON, B Jackson, B. Jackson, BROOKS JACKSON, Belinda Jackson, Brooks Jackson, J B Jackson, J BROOKSJACKSON, J Benjamin Jackson, J Brian Jackson

356

Publications

19.5K

Citations

H-Index

226

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine Makerere University Fred Hutch Cancer Center National Institutes of Health

About

J. Brooks Jackson is an author at Johns Hopkins University specializing in medicine, hiv, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	80	6.9K
2	Engineering	10	10	2.6K
3	Health Sciences	7	7	517
4	Management	3	3	71
5	Education	1	1	15

J. Brooks Jackson

197

Publications

18K

Citations

H-Index

Page 1

	Year	Citations
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial Laura Guay, Philippa Musoke, Thomas R. Fleming, The Lancet ContraceptionNeonatal Single-dose NevirapineTreatment And PreventionPediatricsMaternal Health	1999	1.6K
Maternal Levels of Plasma Human Immunodeficiency Virus Type 1 RNA and the Risk of Perinatal Transmission Patricia García, Leslie A. Kalish, Jane Pitt, New England Journal of Medicine	1999	792
A Whole Blood Immunoassay Using Gold Nanoshells L. R. Hirsch, J. Brooks Jackson, A. Lee, Analytical Chemistry	2003	674
Surface-enhanced Raman scattering on tunable plasmonic nanoparticle substrates J. Brooks Jackson, Naomi J. Halas Proceedings of the National Academy of Sciences Materials SciencePlasmonicsEngineeringPlasmon ResonanceNanomaterials	2004	571
Infrared extinction properties of gold nanoshells Steven J. Oldenburg, J. Brooks Jackson, Sarah L. Westcott, Applied Physics Letters Optical MaterialsEngineeringMetal NanoparticlesMetamaterialsMetallic Nanomaterials	1999	542
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial J. Brooks Jackson, Philippa Musoke, Thomas R. Fleming, The Lancet ContraceptionNeonatal Single-dose NevirapineHivnet 012Treatment And Prevention18-Month Follow-up	2003	523
Silver Nanoshells: Variations in Morphologies and Optical Properties J. Brooks Jackson, Naomi J. Halas The Journal of Physical Chemistry B NanoparticlesOptical MaterialsEngineeringMetal NanoparticlesMetallic Nanomaterials	2001	497
The Relation of Virologic and Immunologic Markers to Clinical Outcomes after Nucleoside Therapy in HIV-Infected Adults with 200 to 500 CD4 Cells per Cubic Millimeter David Katzenstein, Scott M. Hammer, Michael D. Hughes, New England Journal of Medicine	1996	484
Thalidomide for the Treatment of Oral Aphthous Ulcers in Patients with Human Immunodeficiency Virus Infection Jeffrey M. Jacobson, John S. Greenspan, John Spritzler, New England Journal of Medicine	1997	422
Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012) Susan H. Eshleman, Martin Mracna, Laura Guay, AIDS	2001	420

Page 1